Amaero Inc. (ASX:3DA): How Does Its US Listing Fit Its Manufacturing Expansion?

Aditi Sarkar

28 October 2026 08:17 PM AEDT

Amaero Inc. (ASX:3DA): How Does Its US Listing Fit Its Manufacturing Expansion?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Amaero appears on the supplied ASX gainer list for 28 October 2026.
The company priced a US initial public offering at US$4.25 per common share.
The offering comprised 4,705,883 shares, representing roughly US$20 million before expenses.
Amaero plans to allocate up to approximately US$10 million of net IPO proceeds to capital equipment.
Its operating focus includes titanium and refractory alloy powders and specialised component manufacturing.

Amaero Inc. (ASX:3DA) manufactures specialised titanium and refractory alloy spherical metal powders in Tennessee, supplying advanced manufacturing applications in defence, aerospace and other industries. Its recent US capital-markets developments have placed the company in focus alongside its manufacturing expansion. The supplied market classification identifies ASX:3DA as a gainer on 28 October 2026; that classification is separate from the operational announcements discussed below, and does not establish what caused the movement.

US Initial Public Offering and Dual-Market Structure

Amaero (ASX:3DA) announced on 15 October 2026 that it had priced a US initial public offering of 4,705,883 common shares at US$4.25 each, representing approximately US$20 million in gross proceeds. The company also granted underwriters a 30-day option to acquire up to 705,882 additional shares at the offering price, less applicable discounts and commissions. Its announcement stated that common shares were expected to begin trading on the Nasdaq Capital Market under AMRO on 15 October, with closing anticipated on 16 October subject to customary conditions.

The US prospectus confirmed that each ASX-listed CHESS Depositary Interest represents one-fortieth of an Amaero common share. The ASX:3DA quotation and Nasdaq share structure therefore represent different trading units.

Where the Capital Is Intended to Go

According to its 15 October release, Amaero intends to deploy up to approximately US$10 million of net offering proceeds towards capital equipment over the following 12 months. The remainder is intended for general corporate purposes, including working capital, operating expenditure and research and development. These are stated uses of proceeds, rather than evidence that the spending has already occurred or that production volumes have increased.

Manufacturing Portfolio and Commercial Development

Amaero’s US operations produce spherical powders from titanium and refractory alloys for additive manufacturing and other specialised processes. Its activities also encompass powder metallurgy hot isostatic pressing, known as PM-HIP, for manufacturing components with near-final shapes. These capabilities serve applications where material properties and production requirements can be demanding.

A company quarterly release dated 21 April 2026 reported that secured titanium powder revenue in the fourth quarter of FY26 was 62% above the third quarter and reflected full utilisation of capacity during the reporting quarter. It also described shipments to Titomic under a previously announced purchase order and active work on refractory alloy and PM-HIP contracts. Those reported developments provide operating context, although quarterly secured revenue should not be confused with a full-year earnings measure.

Financial and Execution Considerations

The official ASX company profile reports annual revenue of approximately A$18.14 million and a net loss of approximately A$36.51 million. These figures indicate that commercial activity and profitability need to be considered separately. The company’s prospective equipment purchases, research expenditure and manufacturing commitments can require cash ahead of the recognition of related sales.

For ASX:3DA, operational considerations include customer qualification, production interruptions, capital spending and converting contracts into revenue. US listing does not remove these risks.

Key Insights

Amaero’s October IPO documents establish the key terms of its US equity raising and intended equipment investment. They also confirm the continued ASX CDI structure under ASX:3DA. Its specialist manufacturing business has identifiable commercial applications, while reported net losses and the demands of scaling production remain relevant financial considerations. The gainer classification supplied for 28 October 2026 should not be interpreted as proof that any particular announcement caused that session’s movement.

FAQs

Q: What does Amaero Inc. manufacture?

A: It manufactures titanium and refractory alloy powders and develops PM-HIP manufacturing capabilities.

Q: What is Amaero’s ASX ticker?

A: Its CHESS Depositary Interests trade under ASX:3DA.

Q: What were the terms of the US IPO?

A: The announced offering comprised 4,705,883 common shares at US$4.25 each.

Q: What is the Nasdaq ticker?

A: Amaero’s common shares were approved for the Nasdaq Capital Market under AMRO.

Q: What will the company use IPO proceeds for?

A: Its stated plans include up to approximately US$10 million for equipment, with other proceeds for general corporate needs.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.